Effects of oral administration and intravenous injection of polygalacturonic acid on the immunomodulation and gut microbiota in UC mice

Int J Biol Macromol. 2022 Sep 30:217:150-160. doi: 10.1016/j.ijbiomac.2022.07.039. Epub 2022 Jul 10.

Abstract

This study aimed to compare the differences between oral administration and intravenous injection of polygalacturonic acid (PGA) in the regulation of immune and intestinal microflora in ulcerative colitis (UC) mice. PGA was administered orally or intravenously. PGA in the high-dose ig group was the most effective in treating UC by increasing colon length and downregulating disease activity index, histopathological score and proinflammatory cytokine levels. In spleen, the efficacy of PGA on restoring Th17/Treg balance in the high-dose iv group was better than that in the high-dose ig group, the opposite was observed in the lamina propria. The level of colonic IL-17A in the high-dose ig group was lower than that in the high-dose iv group, the opposite was observed for that of colonic IL-10. Western blot and immunohistochemistry analysis revealed that PGA in the high-dose ig group decreased the protein expression of RORγt, and increased that of FOXP3. Furthermore, PGA in the high-dose ig group was more effective than that in the high-dose iv group in improving the intestinal microflora structure. Our results suggest that in immune regulation, oral PGA is more effective in the lamina propria and gut microbiota while intravenous PGA is more effective in the spleen.

Keywords: Gut microbiota; Immunomodulation; Polygalacturonic acid.

MeSH terms

  • Administration, Oral
  • Animals
  • Colitis, Ulcerative* / chemically induced
  • Colitis, Ulcerative* / drug therapy
  • Colon
  • Dextran Sulfate / pharmacology
  • Disease Models, Animal
  • Gastrointestinal Microbiome*
  • Immunomodulation
  • Injections, Intravenous
  • Mice
  • Pectins
  • T-Lymphocytes, Regulatory

Substances

  • Dextran Sulfate
  • Pectins
  • polygalacturonic acid